We live in the era of the most advanced medical technologies the world has ever seen, but are we really that much healthier for it? According to the CDC, 6 in 10 adults in the US are living with at least one chronic disease, 4 in 10 have two or more. In the wake of the pandemic, those numbers look primed to keep going up.
Modern health care systems treat these illnesses after the fact, but what if healthcare began long before we got sick? And what if the best preventative medicine starts with something as simple as the food we eat? With today's science-based advancements in nutrition for health and longevity, the old adage "food is medicine" may be closer to the truth than ever before.
Today's guest is Dr. Joseph Antoun, the CEO and Chairman of L-Nutra, a unique nutri-tech company applying cutting-edge science to nutrition with the aim of helping people live longer, healthier lives. Dr. Antoun served as the Chairman of the Board at the Global Healthspan Policy Institute and as a member of Forbes Business Development Council. Before joining L-Nutra, Dr. Antoun was the CEO of Health Systems Reform, the Co-Director of the Center for Health Policy at the University of Chicago, and the Co-Editor in Chief of the Journal of Helath Systems and Reform, among other accomplishments.
In this episode, we speak about the science behind L-Nutra's fasting mimicking technology, what they see as their three areas of growth potential, and how their programs and products stand out in a crowded market.
In the increasingly crowded and competitive corporate and financial ecosystem, it’s harder than ever for companies to break through the clutter and be heard. The media, investors, agenda-driven influencers, even customers and competitors, are defining your business story on their terms. Therefore, it is imperative that companies take control and proactively drive the conversation with stakeholders in an effort to build & maintain equity value.
In Welcome to the Arena from ICR, Co-Founder & CEO of ICR, Tom Ryan, interviews key business and financial players who influence the fate of public or aspiring public companies in the capital markets. As a former Wall Street Journal ranked sell-side equity analyst and the founder of one of the largest strategic communications firms in the world, Tom understands what it takes to navigate this complex environment.
This is a forum for CEOs, CFOs, institutional investors, sell-side analysts, financial journalists, private equity professionals and other financial community participants to share their stories and give advice in an open and candid conversation.
For more information, visit http://www.icrinc.com